An Expert's Perspective on Advancing Treatment Progress for Blood Cancers
Read Transcript
Download Transcript 
Share This Video
Take Our SurveyDr. Steven Rosen, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University in Chicago, expresses his excitement about advancements in blood cancer treatments presented at the 2012 American Society of Hematology annual meeting. Dr. Rosen explains one of the key factors for determining the best treatment course is understanding the genetics of each individual's cancer. As survivorship increases, the paradigm of care is shifting to focus on long term disease management and maintaining quality of life.
Health Topics: Chronic Lymphocytic Leukemia , Chronic Myelogenous Leukemia
Get Email Updates:
Get updated automatically when new content about Chronic Lymphocytic Leukemia has been posted.
Privacy Policy
Privacy Policy
Chronic Lymphocytic LeukemiaMore Health Topics
Experts & Guests
|
Steven T. Rosen, M.D.
Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Hospital
Dr. Steven Rosen is the Genevieve Teuton Professor of Medicine and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He received his medical degree from the Northwestern University Feinberg School of Medicine and completed his residency training at McGaw Medical Center of Northwestern University. Dr. Rosen is board certified in hematology, internal medicine and medical oncology.
more >
|
|
|
